|
Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
|
6 |
|
Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
|
3 |
|
Cross-Disorder Group of the Psychiatric Genomics Consortium
|
3 |
|
GROUP
|
2 |
|
Psychiatric Genomics Consortium Substance Use Disorders Workgroup
|
2 |
|
Spit for Science Working Group
|
2 |
|
Understanding Society Scientific Group
|
2 |
|
Varenicline Phase 3 Study Group
|
2 |
|
ADHD Working Group of the Psychiatric Genomics Consortium
|
1 |
|
ADHD Working Group of the Psychiatric Genomics Consortium (PGC)
|
1 |
|
Australian Ovarian Cancer Study Group
|
1 |
|
Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium
|
1 |
|
Bipolar Disorder Working Group of the Psychiatric Genetics Consortium
|
1 |
|
CHARGE inflammation working group
|
1 |
|
Cross-Disorder Group of the Psychiatric Genomics Consortium. Electronic address: plee0@mgh.harvard.edu
|
1 |
|
eQTL manuscript working group:
|
1 |
|
FTND meta-analysis group
|
1 |
|
GAIN Collaborative Research Group
|
1 |
|
Genetic Risk and Outcome of Psychosis (GROUP) investigators
|
1 |
|
Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON)
|
1 |
Sign in